Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-14
DOI
10.1186/s13287-020-01911-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
- (2020) Jie Su et al. NATURE
- Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis
- (2019) Liting Zhang et al. MEDICAL SCIENCE MONITOR
- Chronic Hepatitis B Infection
- (2018) Lydia S. Y. Tang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Contextual determinants of TGFβ action in development, immunity and cancer
- (2018) Charles J. David et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Comparison of Two Protocols of Carbon Tetrachloride-Induced Cirrhosis in Rats – Improving Yield and Reproducibility
- (2018) José I Fortea et al. Scientific Reports
- Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis
- (2018) Yongting Zhang et al. Stem Cell Research & Therapy
- A pooled analysis of mesenchymal stem cell-based therapy for liver disease
- (2018) Lu Zhao et al. Stem Cell Research & Therapy
- Recognizing the Molecular Multifunctionality and Interactome of TIMP-1
- (2018) Barbara Grünwald et al. TRENDS IN CELL BIOLOGY
- Chronic hepatitis B virus infection
- (2018) Wai-Kay Seto et al. LANCET
- Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice
- (2017) Su Yeon An et al. GASTROENTEROLOGY
- Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-β1/Smad signaling pathway
- (2017) Shi-Pin Wu et al. Experimental and Therapeutic Medicine
- ORAI channels are critical for receptor-mediated endocytosis of albumin
- (2017) Bo Zeng et al. Nature Communications
- Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis
- (2016) Shuji Terai et al. JOURNAL OF GASTROENTEROLOGY
- Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional study
- (2016) Jue Liu et al. LANCET INFECTIOUS DISEASES
- miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis
- (2016) Cong Wang et al. Scientific Reports
- Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway
- (2015) LI-TING ZHANG et al. Molecular Medicine Reports
- Systematic review: the effects of autologous stem cell therapy for patients with liver disease
- (2014) J. K. Moore et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High glucose enhances store-operated calcium entry by upregulating ORAI/STIM via calcineurin-NFAT signalling
- (2014) Nikoleta Daskoulidou et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Effect of bone marrow mesenchymal stem cells on the Smad expression of hepatic fibrosis rats
- (2014) Zhen-Chang Wang et al. Asian Pacific Journal of Tropical Medicine
- Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism
- (2012) Zhao-hui Qin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation